FTRNX
Price
$193.11
Change
+$0.99 (+0.52%)
Updated
Jul 16 closing price
Net Assets
4.12B
GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
Interact to see
Advertisement

FTRNX vs GFACX

Header iconFTRNX vs GFACX Comparison
Open Charts FTRNX vs GFACXBanner chart's image
Fidelity Trend
Price$193.11
Change+$0.99 (+0.52%)
VolumeN/A
Net Assets4.12B
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets322.72B
FTRNX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTRNX vs. GFACX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRNX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. FTRNX (4.12B). FTRNX pays higher dividends than GFACX: FTRNX (0.55) vs GFACX (0.00). FTRNX was incepted earlier than GFACX: FTRNX (67 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than FTRNX (0.59). FTRNX is a more actively managed with annual turnover of: 64.00 vs. GFACX (25.00). FTRNX has a lower initial minimum investment than GFACX: FTRNX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 7.11 vs. FTRNX (0.18). FTRNX return over 5 years is better than : 52.31 vs. GFACX (35.91).
FTRNXGFACXFTRNX / GFACX
Total Expense Ratio0.591.3643%
Annual Report Gross Expense Ratio0.591.3643%
Fund Existence67 years24 years-
Gain YTD5.79511.29251%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4.12B323B1%
Annual Yield % from dividends0.550.00-
Returns for 1 year0.187.112%
Returns for 3 years64.8852.01125%
Returns for 5 years52.3135.91146%
Returns for 10 years111.8963.31177%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp